TRISEQUENS

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug TRISEQUENS contains a combination of these active pharmaceutical ingredients (APIs):

1 Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

2 Norethisterone UNII 9S44LIC7OJ - NORETHINDRONE ACETATE

Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. Read about Norethisterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03FB05	Norethisterone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FB Progestogens and estrogens, sequential preparations
Discover more medicines within G03FB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01928997, 01929005
Country: EE	Ravimiamet	Identifier(s): 1030453
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60706
Country: FR	Base de données publique des médicaments	Identifier(s): 64725221
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 34496
Country: HK	Department of Health Drug Office	Identifier(s): 33985
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-919057630
Country: IE	Health Products Regulatory Authority	Identifier(s): 48844
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001920, 1085839
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 30341
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5202
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100068006, 100418825, 100431122
Country: SG	Health Sciences Authority	Identifier(s): 06011P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676090297
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/21.8.2/212